Bessemer Group Inc Charles River Laboratories International, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 23,476 shares of CRL stock, worth $4.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,476

Previous 8,658 171.15%

Holding current value

$4.64 Million

Previous $1.79 Million 158.47%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $2.79 Million - $3.63 Million	14,818 Added 171.15%	23,476 $4.62 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $1,857 - $2,418	9 Added 0.1%	8,658 $1.79 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $1.44 Million - $1.94 Million	7,095 Added 456.56%	8,649 $2.34 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $13,161 - $19,107	-80 Reduced 4.9%	1,554 $367,000
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $6,416 - $7,181	-33 Reduced 1.98%	1,634 $320,000
Q2 2023 Aug 10, 2023	BUY	$183.71 - $210.25 $74,218 - $84,941	404 Added 31.99%	1,667 $351,000
Q1 2023 May 10, 2023	SELL	$191.89 - $259.92 $11,705 - $15,855	-61 Reduced 4.61%	1,263 $255,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $118,463 - $150,292	601 Added 83.13%	1,324 $289,000
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $45,062 - $61,883	-247 Reduced 25.46%	723 $142,000
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $155,138 - $229,823	-760 Reduced 43.93%	970 $208,000
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $66,432 - $94,148	-260 Reduced 13.07%	1,730 $491,000
Q4 2021 Jan 27, 2022	SELL	$351.38 - $448.68 $93,818 - $119,797	-267 Reduced 11.83%	1,990 $749,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $2,981 - $3,666	8 Added 0.36%	2,257 $931,000
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $252,397 - $318,875	858 Added 61.68%	2,249 $832,000
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $111,103 - $133,268	-445 Reduced 24.24%	1,391 $403,000
Q4 2020 Feb 09, 2021	BUY	$222.0 - $252.62 $15,096 - $17,178	68 Added 3.85%	1,836 $458,000
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $18,784 - $24,230	-107 Reduced 5.71%	1,768 $400,000
Q1 2020 Apr 30, 2020	BUY	$98.9 - $178.34 $43,516 - $78,469	440 Added 30.66%	1,875 $237,000
Q2 2019 Jul 19, 2019	SELL	$123.4 - $148.55 $10,982 - $13,220	-89 Reduced 5.84%	1,435 $204,000
Q1 2019 May 13, 2019	SELL	$104.82 - $146.73 $16,247 - $22,743	-155 Reduced 9.23%	1,524 $221,000
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $8,512 - $11,115	-81 Reduced 4.6%	1,679 $190,000
Q3 2017 Nov 03, 2017	BUY	$96.72 - $109.26 $170,227 - $192,297	1,760	1,760 $190,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Charles River Laboratories International, Inc. Transaction History